Red Mountain Acquires Yellow Pine Antimony Project in Idaho

Red Mountain Mining Limited (ASX: RMX) has expanded its critical minerals portfolio with the acquisition of the highly prospective Yellow Pine Antimony Project in Idaho’s Stibnite Mining District. Located less than 2 km from Perpetua Resources’ Stibnite Gold-Antimony Project, which hosts 4.8Moz of gold and 148Mlbs of antimony in reserves, the project lies in one of the most significant antimony-rich regions in the United States.

Mineralisation in the district is structurally controlled by regional faults and hosted within both the Idaho Batholith and older sedimentary units, providing favorable conditions for gold-antimony systems. The Yellow Pine Project contains mapped tectonic breccias, historic workings, and prospective host rocks, all pointing to strong exploration potential. The acquisition, completed through claim staking and funded internally, follows RMX’s recent Utah Antimony Project acquisition and comes at a time of growing U.S. government support for critical mineral supply chains. RMX is well-positioned to advance exploration while also evaluating additional U.S. opportunities and a potential U.S. stock exchange listing.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com